; disciplinary action for unauthorized disclosure An individual or entity that submits information to the reporting system under subsection (b) shall not be required to provide their name. (f) Relationship to other reporting systems The voluntary reporting system established under this section shall supplement, and not supplant, any other requirements to submit reports under any other reporting system. . 403. Evaluation of the Federal Select Agent Program and related policies (a) In general Not later than 4 years after the date of enactment of this Act, the National Science Advisory Board for Biosecurity (referred to in this section as the Board ) established pursuant to section 404O of the Public Health Service Act ( 42 U.S.C. 283r ) shall be charged with assessing the framework for biosafety and biosecurity oversight, particularly with respect to mitigating risks to the United States population with respect to biological threats. The findings of the Board shall address scientific advancements and integration of the Program and other related Federal policies and frameworks for biosafety and biosecurity. The findings of the Board shall be transmitted to the President. (b) Framework (1) In general The recommendations developed under subsection (a) shall include a proposed framework for an integrated approach to the oversight of biological research that raises significant biosafety and biosecurity concerns, which may include proposals to harmonize and modernize relevant Federal policies such as the following: (A) The Federal Select Agent Program. (B) Federal policies relating to dual-use research of concern. (C) Federal policies related to federally funded research involving enhanced pathogens of pandemic potential. (D) The Biosafety in Microbiological and Biomedical Laboratories Manual of the Department of Health and Human Services, and other related guidance documents. (E) The Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules of the National Institutes of Health. (2) Requirements